||High levels of secretagogin have been found in patients suffering from hypoxic brain injury.
Similar levels have been determined in both subtypes of stroke during acute phase.
||Similar levels have been determined in both subtypes of stroke during acute phase.
||Higher circulating levels of HMGB1 are associated with poor outcome 1 year after stroke.
||Patients who died after ischemic stroke had higher levels of ALCAM/CD166.